1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Moderate to Severe Opioid-use Disorder: new trials by email Literature Review of Moderate to Severe Opioid-use Disorder trials Research Report on Moderate to Severe Opioid-use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users Transmucosal Buprenorphine, Extended-release Buprenorphine - Moderate to Severe Opioid-use Disorder | Phase 4 | Completed | Indivior Inc. | 785 | 2021-10-26 | 2026-02-06 |
Sublocade (1)
Indivior Inc. (1)
Canada (1) · United States (1)